Clinical Trials Logo

Filter by:
NCT ID: NCT06126562 Completed - Pharmacokinetic Clinical Trials

A Pharmacokinetic Study of Lanifibranor in Healthy Adult Chinese Subjects

Start date: October 31, 2023
Phase: Phase 1
Study type: Interventional

This will be a randomized, open-label parallel design and single centre study conducted at the 1st hospital affiliated to Jilin University. Approximately 24 healthy Chinese volunteers, male and female will be recruited and divided into two equal groups (12 subjects per dose). The primary objective of this study is to evaluate the pharmacokinetic profile of lanifibranor after single dose and multiple doses 800 and 1200 mg in healthy adult Chinese subjects. The secondary objective is to evaluate the safety of lanifibranor after single dose and multiple doses 800 and 1200 mg in healthy adult Chinese subjects.

NCT ID: NCT06125158 Completed - Clinical trials for Ankle Injuries and Disorders

Effects of Hip Strength Training and Neuromuscular Electrical Stimulation on Functional Ankle Instability

Start date: October 18, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to compare the effects of two methods of elevating hip muscle strength on functional ankle instability(FAI). . The main question[s] it aims to answer are: - Whether hip strength training and neuromuscular electrical stimulation of the gluteal muscles, respectively, based on conventional ankle training improves dysfunction in patients with FAI? - Is there a difference in the efficacy of the above two interventions for FAI?

NCT ID: NCT06124417 Completed - Clinical trials for Adverse Reaction to Drug

Efficacy and Safety of Sertraline in the Treatment of Maintenance Hemodialysis Patients With Depression

Start date: January 10, 2022
Phase: Phase 4
Study type: Interventional

Depression is a common mental disorder in patients undergoing maintenance hemodialysis (MHD), which increases the risk of cardiovascular events, hospitalization rates, and mortality, but has not received enough attention from patients and medical staff. Sertraline is a selective serotonin reuptake inhibitor with fewer adverse reactions and higher safety compared to other antidepressants. This study aims to investigate the efficacy and safety of sertraline in patients undergoing MHD with depression. This study used a randomized controlled design and evaluated the depression status of the patients using the Hamilton Depression Scale (HAMD). MHD patients with comorbid depression were recruited and divided into the treatment group and the control group. The treatment group received sertraline for antidepressant therapy, while the control group did not receive any antidepressant medication. To investigate the efficacy and safety of sertraline before and after intervention.

NCT ID: NCT06124404 Completed - Clinical trials for Mechanically Ventilated Patients

Step 1 of A Two-step Trial to Evaluate the Effectiveness and Safety of Remimazolam Besylate for Sedation in ICU Patients

Start date: April 8, 2022
Phase: Phase 2
Study type: Interventional

This is a Phase II, dose-escalation clinical trial conducted in mechanically ventilated patients receiving sedation no longer than 24 hours. The efficacy, safety, and pharmacokinetics of remimazolam besylate were evaluated using a randomized, single-blind design.

NCT ID: NCT06124170 Completed - Knee Osteoarthritis Clinical Trials

Improved Pain Management in Knee Osteoarthritis-related Surgeries

Start date: March 1, 2016
Phase:
Study type: Observational

In recent years, pain management coordinated with enhanced recovery after surgery (ERAS) has been widely applied and rapidly developed in orthopedics, showing promising prospects. Since 2016, our hospital has used a series of continuously improved pain management schemes for patients with knee OA who underwent total knee arthroplasty (TKA), unicompartmental knee arthroplasty (UKA), and high tibial osteotomy (HTO). Here, we retrospectively analyze these patients' clinical data to compare the effects of different pain intervention measures during the perioperative period on postoperative pain, functional exercise, hospital stay, and prognosis of the three surgical methods in an attempt to provide a feasible solution for pain management of these patients.

NCT ID: NCT06120478 Completed - Machine Learning Clinical Trials

Prediction of Risk Factors for Adverse Events After Head and Neck Vascular Recanalization Surgery Based on Machine Learning Models

Start date: January 1, 2019
Phase:
Study type: Observational

Prediction of risk factors for adverse events after head and neck vascular recanalization surgery based on machine learning models

NCT ID: NCT06119347 Completed - Clinical trials for AKI Incidence of Cancer Patients Receiving AntiVEGF or ICIs

Acute Kidney Injury in Cancer Patients Receiving Anti-Vascular Endothelial Growth Factor Monoclonal Antibody vs Immune Checkpoint Inhibitors

Start date: January 1, 2020
Phase:
Study type: Observational

The goal of this a retrospective real-world study is to compare the AKI events in cancer patients receiving anti-vascular endothelial growth factor monoclonal antibody (AntiVEGF) vs immune checkpoint inhibitors (ICIs). The main question it aims to answer is whether the choice between AntiVEGF and ICIs affects the risks of acute kidney injury in cancer patients. Cancer patients receiving AntiVEGF will be compared to those treated with ICIs to see if the AKI incidence is higher in patients receiving ICIs.

NCT ID: NCT06118216 Completed - Clinical trials for Rectus Abdominis and External Oblique Muscle Infiltration Analgesia

Costal Cartilage Donor-site Pain: Does Abdominal Muscle Infiltration Analgesia Work?

Start date: December 1, 2022
Phase: N/A
Study type: Interventional

Donor-site pain is an adverse effect of autologous ear reconstruction. A well-planned pain management protocol is needed. The objective of this study was to introduce rectus abdominis and external oblique muscle infiltration analgesia (RAM+EOM-IA) in autologous ear reconstruction and to evaluate its efficacy and safety.

NCT ID: NCT06117787 Completed - Blood Pressure Clinical Trials

Blood Pressure Monitor Clinical Test (Cuff Range: 13.5cm-19.5cm)

Start date: April 2, 2022
Phase:
Study type: Observational

The purpose of this study is to verify the accuracy of the blood pressure cuffs with blood pressure monitor device. Cuff circumference is 13.5cm-19.5cm.

NCT ID: NCT06117553 Completed - Colonoscopy Clinical Trials

Thorough Flushing Strategy During Colonoscopy Examination

Start date: August 1, 2023
Phase:
Study type: Observational

The investigators plan to adopt a thorough flushing strategy when withdrawing the endoscope, and have zero tolerance for the liquid and foam in the intestinal lumen. Observe and compare the impact of this strategy with traditional limited degree suction methods on the results of colonoscopy. The research group and the control group respectively adopted a thorough flushing strategy and a limited flushing strategy, and compared the total time of colonoscopy examination, the time of withdrawal, the detection rate of polyps, the detection rate of small polyps, and the amount of flushing fluid between the two groups. Analyze the value of thorough flushing strategy for the efficiency and quality of colonoscopy examination.